Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Retatrutide is the newest weight loss medication that acts as a triple agonist at GLP-1, GIP, and glucagon receptors
Swapping in the triple agonist is the upgrade path, with the trade-off being that the specific pairing has not been formally trialed
Weight Loss Medication Tracker Phaze supports 14 GLP-1 medication options including Ozempic, Mounjaro, Wegovy, Wegovy Pill, Zepbound, Rybelsus, Retatrutide, Survodutide, Orforglipron, Pemvidutide, Bioglutida, and CagriSema
Zepbound (Tirzepatide) By targeting two hormonesGLP-1 and GIPZepbound enhances weight loss results
US$ 27.64
US$ 23.75
US$ 24.55
